ID,Vitamin D,Vitamin D dose,Size,Patient setting,Expectation,Notes,URL,PDF,Country,Region,Date,Completion,Trial status,Design,Blinding,Arms,COVID-19 status,Outcome,Treatment
CTRI/2020/06/026191,Y,60k IU a week for 5 weeks,500,"Healthy Exposed, Healthcare Workers",Success,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45075,NA,India,New Delhi,2020-Jun,NA,Not Recruiting,Randomised,Double,1,Healthy,NA,Other + Vitamins
NCT04476745,Y,"50,000 IU vitamin D3",100,Healthy Unexposed,Success,,https://clinicaltrials.gov/show/NCT04476745,NA,Jordan,Amman,2020-Jul,NA,Recruiting,Randomised,Open-Label,2,Healthy,"IL-1, IL-6, Tumor Necrosis Factor (Any)",Vitamins
NCT04386850,Y,1000 IU/day for 2 months,1500,"Hospital, Healthy unexposed",Success,,https://ClinicalTrials.gov/show/NCT04386850,NA,Iran,Tehran,2020-May,2020-Nov,Recruiting,Randomised,Quadruple,2,NA,"Viral Load or Clearance, Dyspnea","Standard of care, Vitamins"
NCT04366908,Y,Calcifediol,1008,Hospital,Success,,https://ClinicalTrials.gov/show/NCT04366908,NA,Spain,Cordoba,2020-Apr,2021-Jun,Recruiting,Randomised,Open-Label,2,NA,"Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Dyspnea, Adverse Events","Standard of care, Vitamins"
NCT04641195,Y,"180,000 international units (IU) of vitamin D3 at enrollment, followed by 2000 IU once per day from enrollment to 8 weeks",700,Hospital,Success,,https://ClinicalTrials.gov/show/NCT04641195,NA,India,Maharashtra,2020-Nov,2021-Nov,Not Recruiting,Randomised,Quadruple,4,Confirmed,"Mortality, IL-6, IgG, IgM or IgA","Standard of care, Vitamins, Vitamins + Zinc, Zinc"
NCT04536298,Y,9600 IU/day,2700,Outpatient,Success,,https://ClinicalTrials.gov/show/NCT04536298,NA,United States,Massachusetts,2020-Sep,2021-Jun,Recruiting,Randomised,Quadruple,2,Confirmed,"Mortality, ICU Admission, Hospitalization, Visits or Returns to Emergency Department","Standard of care, Vitamins"
NCT04482673,Y,"20,000 IU/day for 3 days) followed by high dose (6000 IU vitamin D/day)",140,Outpatient,Success,,https://clinicaltrials.gov/show/NCT04482673,NA,United States,"Washington, Dc",2020-Jan,NA,Recruiting,Randomised,Quadruple,4,Suspected,Anti SARS-COV-2 Titers,"Standard of care, Vitamins"
2020-001717-20,Y,Calcifediol,NA,Hospital,Success,,https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001717-20/ES/,NA,Spain,Madrid,2020-Apr,NA,Recruiting,Randomised,Open-Label,2,Confirmed,"Mortality, ICU Admission, Hospitalization, Hospital Discharge, Viral Load or Clearance, Labor Absenteeism, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Dyspnea, Adverse Events, IL-2, IL-4, IL-6, IL-8, IL-12, Tumor Necrosis Factor (Any), Interferon (Any), MIP-1, Respiratory Rate",Vitamins
NCT04551911,Y,Calcifediol (Rayaldee),160,Healthy Exposed,Success,,https://ClinicalTrials.gov/show/NCT04551911,NA,United States,Florida,2020-Sep,2021-May,Recruiting,Randomised,Quadruple,2,Confirmed,NA,"Standard of care, Vitamins"
IRCT20200401046909N2,Y,1000 IUs of 25(OH)D daily for 8 wks,540,"Healthy Exposed, Healthcare Workers",Success,,http://en.irct.ir/trial/47010,NA,Iran,Tehran,2020-Apr,2020-Oct,Completed,Randomised,Double,2,NA,"Cough, Fever, Dyspnea, Radiographic Findings","Standard of care, Vitamins"
NCT04335084,Y,,600,Healthcare Workers,Failure,vitamin D given in the placebo arm,https://clinicaltrials.gov/show/NCT04335084,NA,United States,"Washington, Dc",2020-Feb,NA,Recruiting,Single-Arm,Double,2,Healthy,"Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Serious Adverse Events","HCQ + Vitamins + Zinc, Standard of care"
NCT04476680,Y,"1000 IU/day D3 for 4 weeks, and 400 IU/d D3 as a maintenance dose",900,Healthy Unexposed,Failure,Low dose vitamin D is unlikely to show an effect in an open label trial. Also seroconversion is an ambiguos endpoint. ,https://clinicaltrials.gov/show/NCT04476680,NA,United Kingdom,London,2020-Jul,NA,Recruiting,Non-Randomised,Open-Label,2,Healthy,NA,"Standard of care, Vitamins"
2020-002274-28,Y,100k IU vitamin D,NA,Hospital,Failure,Bolus dose administered late in the disease course is unlikely to help.,https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-002274-28/ES/,NA,Spain,Madrid,2020-May,NA,Recruiting,Randomised,Unspecified,2,Confirmed,"Mortality, ICU Admission, Hospitalization, Viral Load or Clearance","Standard of care, Vitamins"
2020-001903-17,Y,100k IU vitamin D,NA,Hospital,Failure,Bolus dose administered late in the disease course is unlikely to help.,https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001903-17/ES/,NA,Spain,Madrid,2020-May,NA,Recruiting,Randomised,Open-Label,2,Confirmed,"Mortality, ICU Admission, Hospital Discharge, C-Reactive Protein, Ferritin, IL-6, LDH","TCZ, TCZ + Vitamins"
NCT04411446,Y,500k IU vitamin D,1264,Hospital,Failure,Bolus dose administered late in the disease course is unlikely to help.,https://clinicaltrials.gov/show/NCT04411446,NA,Argentina,Buenos Aires,2020-May,NA,Recruiting,Randomised,Quadruple,2,Confirmed,"Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)","Standard of care, Vitamins"
NCT04449718,Y,,240,Hospital,Failure,Bolus dose administered late in the disease course is unlikely to help.,https://ClinicalTrials.gov/show/NCT04449718,NA,Brazil,Sao Paulo,2020-Jun,2020-Oct,Completed,Randomised,Quadruple,2,Suspected,"Mortality, ICU Admission, Hospitalization, C-Reactive Protein","Standard of care, Vitamins"
CTRI/2020/06/026189,Y,60000 IU Single Dose,210,Hospital,Failure,Bolus dose administered late in the disease course is unlikely to help.,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45029,NA,India,New Delhi,2020-Jun,NA,Not Recruiting,Randomised,Double,2,Confirmed,"ICU Admission, Hospitalization, C-Reactive Protein",Other + Vitamins
ACTRN12620000557932,Y,,200,Hospital,Failure,vitamin D in the placebo arm,https://anzctr.org.au/ACTRN12620000557932.aspx,NA,Australia,Canberra,2020-Nov,NA,Recruiting,Randomised,Open-Label,2,Confirmed,"Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO",HCQ + Zinc + Vitamins + AZT
IRCT20200324046850N1,Y,50k IU weekly,100,Hospital,Failure,Bolus dose administered late in the disease course is unlikely to help.,http://en.irct.ir/trial/46732,NA,Iran,Khuzestan,2020-Mar,2020-Jul,Completed,Randomised,Double,4,NA,"Cough, Fever, Dyspnea","Other, Standard of care, Vitamins, Vitamins + Other"
NCT04334005,Y,25k IU vitamin D,200,Outpatient,Failure,Bolus dose administered late in the disease course is unlikely to help.,https://clinicaltrials.gov/show/NCT04334005,NA,Spain,Madrid,2020-Mar,NA,Not Recruiting,Randomised,Double,2,Confirmed,"Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms","Standard of care, Vitamins"
NCT04482686,Y,,300,Unclear,Failure,vitamin D in the placebo arm,https://clinicaltrials.gov/show/NCT04482686,NA,United States,"Washington, Dc",2020-Jul,NA,Recruiting,Randomised,Triple,4,Confirmed,NA,"Ivermectin + Doxycycline + Zinc + Vitamins, Vitamins + Zinc"
NCT04344041,Y,"400k IU treatment, 50k IU in the control",260,Unclear,Failure,Large bolus dose and vitamin D in the control arm,https://ClinicalTrials.gov/show/NCT04344041,NA,France,Paris,2020-Apr,2021-May,Recruiting,Randomised,Open-Label,2,NA,"Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious Adverse Events",Vitamins
IRCT20110726007117N11,Y,,210,Unclear,Failure,Bolus dose administered late in the disease course is unlikely to help.,http://en.irct.ir/trial/48287,NA,Iran,Razavi Khorasan,2020-Jul,2021-Jan,Completed,Randomised,Double,2,Confirmed,"C-Reactive Protein, Glucose","Standard of care, Vitamins"
NCT04395768,Y,,200,Unclear,Failure,vitamin D in the placebo arm,https://ClinicalTrials.gov/show/NCT04395768,NA,Australia,Victoria,2020-May,2021-Sep,Recruiting,Randomised,Double,6,Confirmed,"Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified)",HCQ + AZT + Zinc + Vitamins
NCT04525820,,,80,Hospital,,,https://ClinicalTrials.gov/show/NCT04525820,NA,Switzerland,Bern,2020-Aug,2021-May,Recruiting,Randomised,Quadruple,3,Confirmed,"Mortality, ICU Admission, Hospitalization",Vitamins
IRCT20180425039414N3,,,80,Hospital,,,http://en.irct.ir/trial/48083,NA,Iran,Tehran,2020-Jun,2020-May,Completed,Randomised,Open-Label,2,Confirmed,Hospitalization,"HCQ + LPV/r, HCQ + LPV/r + Vitamins"
IRCT20190121042444N3,,,78,Hospital,,,http://en.irct.ir/trial/49132,NA,Iran,Tehran,2020-Jul,2021-Feb,Completed,Randomised,Single,2,Confirmed,C-Reactive Protein,"Standard of care, Vitamins + Other"
NCT04363216,,,66,Hospital,,,https://clinicaltrials.gov/show/NCT04363216,NA,United States,Pennsylvania,2020-Apr,NA,Not Recruiting,Randomised,Open-Label,2,NA,Clinical Improvement Score (Any),"Standard of care, Vitamins"
NCT04344184,,,60,Hospital,,,https://ClinicalTrials.gov/show/NCT04344184,NA,United States,Virginia,2020-Apr,2021-May,Recruiting,Randomised,Quadruple,2,NA,"Clinical Improvement Score (Any), Fever","Standard of care, Vitamins"
IRCT20190917044805N2,,,60,Hospital,,,http://en.irct.ir/trial/46804,NA,Iran,Tehran,2020-Mar,2020-Oct,Completed,Randomised,Double,2,NA,"Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, Erythrocyte Sedimentation Rate","Standard of care, Vitamins"
IRCT20200516047468N1,,,50,Hospital,,,http://en.irct.ir/trial/48176,NA,Iran,Tehran,2020-May,2020-May,Completed,Randomised,Double,2,Confirmed,Radiographic Findings,"Antibiotics + AZT + LPV/r, Vitamins + Antibiotics + AZT + LPV/r"
CTRI/2020/05/025215,,,50,Hospital,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43769,NA,India,New Delhi,2020-May,NA,Not Recruiting,Randomised,Open-Label,2,Confirmed,Viral Load or Clearance,"Alternative therapy, Vitamins + Zinc"
CTRI/2020/07/026789,,,50,Hospital,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45111,NA,India,New Delhi,2020-Jul,NA,Not Recruiting,Randomised,Unspecified,2,Confirmed,"Clinical Improvement Score (Any), Adverse Events","Antimalarial + Alternative therapy + Vitamins, Standard of care"
NCT04502667,,,40,Hospital,,,https://clinicaltrials.gov/show/NCT04502667,NA,Mexico,Mexico,2020-Apr,NA,Recruiting,Randomised,Open-Label,2,Confirmed,"Ferritin, IL-2","Standard of care, Vitamins"
NCT04770740,,,40,Hospital,,,https://clinicaltrials.gov/show/NCT04770740,NA,Netherlands,Amsterdam,2021-Feb,NA,Recruiting,Randomised,Quadruple,2,Confirmed,NA,"Standard of care, Vitamins"
IRCT20170117032004N3,,,30,Hospital,,,http://en.irct.ir/trial/46564,NA,Iran,East Azarbaijan,2020-Mar,2020-Jul,Completed,Randomised,Open-Label,2,Confirmed,Hospitalization,"Standard of care, Vitamins"
NCT04459247,,,30,Hospital,,,https://clinicaltrials.gov/show/NCT04459247,NA,India,New Delhi,2020-Mar,NA,Not Recruiting,Randomised,Double,2,Confirmed,NA,"Standard of care, Vitamins"
NCT04357782,,,20,Hospital,,,https://ClinicalTrials.gov/show/NCT04357782,NA,United States,Virginia,2020-Apr,2020-Oct,Completed,Single-Arm,Open-Label,2,NA,"Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, Neutrophils, D-Dimer, LDH",Vitamins
IRCT20200319046819N1,,,60,ICU,,,http://en.irct.ir/trial/46838,NA,Iran,Tehran,2020-Apr,2020-Jul,Completed,Randomised,Single,2,NA,"Mortality, Hospitalization, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any), Interferon (Any), White Blood Cell Count, Erythrocyte Sedimentation Rate","Standard of care, Vitamins"
NCT04264533,,,56,ICU,,,https://clinicaltrials.gov/show/NCT04264533,NA,China,Beijing,2020-Apr,NA,Not Recruiting,Randomised,Triple,2,Confirmed,"Mortality, ICU Admission, Clinical Improvement Score (Any), PaO2-FiO2, Respiratory Rate, Hypoxia, Hypoxemia","Standard of care, Vitamins"
IRCT20151228025732N52,,,30,ICU,,,http://en.irct.ir/trial/46963,NA,Iran,Semnan,2020-Apr,2020-Jun,Completed,Randomised,Open-Label,2,NA,"Organ Failure or Dysfunction (SOFA), Respiratory Rate, Radiographic Findings","Melatonin + Vitamins + Sulfate, Standard of care"
NCT04682574,,,15,ICU,,,https://ClinicalTrials.gov/show/NCT04682574,NA,Pakistan,Punjab,2020-Dec,2020-Dec,Recruiting,Randomised,Open-Label,2,Confirmed,"Hospitalization, PaO2-FiO2","Standard of care, Vitamins"
PACTR202006899597082,,,60,Outpatient,,,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103,NA,Madagascar,Antananarivo,2020-May,NA,Not Recruiting,Randomised,Unspecified,3,Confirmed,NA,"Other, Other + Vitamins, Standard of care"
NCT04399746,,,30,Outpatient,,,https://clinicaltrials.gov/show/NCT04399746,NA,Mexico,Mexico,2020-May,NA,Recruiting,Non-Randomised,Open-Label,2,Confirmed,Viral Load or Clearance,"AZT + Ivermectin + Vitamins, Standard of care"
CTRI/2020/07/026675,,,76,"Outpatient, Hospital",,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45731,NA,India,New Delhi,2020-Jul,NA,Not Recruiting,Randomised,Open-Label,2,Confirmed Or Suspected,"Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms","Alternative therapy, HCQ + AZT + Oseltamivir + Vitamins"
NCT04385940,,,64,Unclear,,,https://ClinicalTrials.gov/show/NCT04385940,NA,Canada,Alberta,2020-May,2020-Aug,Not Recruiting,Randomised,Quadruple,2,Confirmed,"ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Lymphocyte Count, Platelet Count",Vitamins
NCT04664010,,,60,Unclear,,,https://ClinicalTrials.gov/show/NCT04664010,NA,China,Shaanxi,2020-Dec,2021-Jan,Not Recruiting,Randomised,Single,6,Confirmed,"Cough, Fever, C-Reactive Protein, IL-6, IL-10, Tumor Necrosis Factor (Any), Erythrocyte Sedimentation Rate, Procalcitonin, SpO2, Respiratory Rate, Radiographic Findings","TCM + Western Medicine, TCM + Western Medicine + Vitamins, Western Medicine"
IRCT20190727044343N3,,,60,Unclear,,,http://en.irct.ir/trial/47062,NA,Iran,Tehran,2020-Jun,2020-Jun,Completed,Randomised,Double,2,Confirmed,"C-Reactive Protein, IL-6, Radiographic Findings","Antivirals, Vitamins"
NCT04468139,,,60,Unclear,,,https://clinicaltrials.gov/show/NCT04468139,NA,Saudi Arabia,Riyadh,2020-May,NA,Recruiting,Single-Arm,Open-Label,1,Confirmed,Hospital Discharge,Alternative therapy + Zinc + Vitamins
CTRI/2020/06/025874,,,60,Unclear,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44684,NA,India,New Delhi,2020-Jun,NA,Not Recruiting,Randomised,Open-Label,2,Confirmed,"Viral Load or Clearance, Cough, Fever, IL-2, IL-6, IL-10, Tumor Necrosis Factor (Any), IgG, IgM or IgA","Alternative therapy, Vitamins + Zinc"
NCT04407286,,,41,Unclear,,,https://clinicaltrials.gov/show/NCT04407286,NA,United States,"Washington, Dc",2020-May,NA,Not Recruiting,Single-Arm,Open-Label,1,Confirmed,NA,Vitamins
CTRI/2020/07/026433,,,25,Unclear,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45252,NA,India,New Delhi,2020-Aug,NA,Not Recruiting,Randomised,Open-Label,2,Confirmed,Clinical Improvement Score (Any),"Alternative therapy, AZT + Vitamins + Other"